0001562180-22-004944.txt : 20220608 0001562180-22-004944.hdr.sgml : 20220608 20220608183734 ACCESSION NUMBER: 0001562180-22-004944 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220606 FILED AS OF DATE: 20220608 DATE AS OF CHANGE: 20220608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Seitz Michelle CENTRAL INDEX KEY: 0001836301 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39941 FILM NUMBER: 221004537 MAIL ADDRESS: STREET 1: C/O SANA BIOTECHNOLOGY, INC. STREET 2: 188 EAST BLAINE STREET, SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sana Biotechnology, Inc. CENTRAL INDEX KEY: 0001770121 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 188 EAST BLAINE STREET, SUIT 400 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: (206) 701-7914 MAIL ADDRESS: STREET 1: 188 EAST BLAINE STREET, SUIT 400 CITY: SEATTLE STATE: WA ZIP: 98102 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-06-06 false 0001770121 Sana Biotechnology, Inc. SANA 0001836301 Seitz Michelle C/O SANA BIOTECHNOLOGY, INC. 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 true false false false Stock Option (Right to Buy) 4.95 2022-06-06 4 A false 65000.00 0.00 A 2032-06-05 Common Stock 65000.00 65000.00 D The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2023 and (ii) immediately prior to Sana Biotechnology, Inc.'s next annual meeting of stockholders following June 6, 2022. /s/ James J. MacDonald, Attorney-in-Fact for Michelle Seitz 2022-06-08